U.S. House · 117th Congress · H.R. 7032
Increasing Transparency in Generic Drug Applications Act of 2022
To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)) with respect to a process to inform persons submitting an abbreviated application for a new drug whether the new drug is qualitatively or quantitatively the same as a listed drug, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Ann M. KusterD-NH-2
- Introduced
- March 9, 2022, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Democrat. Each member is shown with the party they were counted with on the day they signed on. How we count these
Signed on later
- Kim SchrierD-WA-8April 1, 2022